FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for INDERAL LA (propranolol hydrochloride) submitted by ANI Pharmaceuticals, Inc. This action authorizes changes to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Cardiac Arrhythmia
• Essential Tremor
• Hypertension
• Migraine
• Pheochromocytoma

Drugs mentioned

• INDERAL LA (Propranolol hydrochloride)

Snippet

SUPPL AP for INDERAL LA (PROPRANOLOL HYDROCHLORIDE)